Page URL:

Critical window for re-infection with HIV after stem cell transplantation

18 May 2020
Appeared in BioNews 1047

New research, in HIV positive patients being treated for blood cancer, has identified a critical time window after donor stem cell transplantation, during which the expanding donor cells are particularly vulnerable to being infected with HIV.   

Patients with HIV who develop blood cancer may require treatment by allogeneic stem cell transplant, using bone marrow stem cells provided by a healthy donor. During a transplant, most of the patient's original immune cells are destroyed, and the immune system and blood cells are restored from the new donor stem cells.

'These results show a weak point that may explain why allogeneic stem cell transplants may not completely remove the virus from the body, despite a drastic reduction in the number of infected cells' said senior author Dr Julian Schulze zur Wiesch from the German Centre for Infection Research. 

Stem cell transplantation in HIV positive patients has been the only medical intervention found to cure HIV (see BioNews 1039), however in nearly all cases HIV infection persists after transplantation.

In a new study it was discovered that immune cells generated from the donor stem cells are at risk of being infected with HIV during the first few weeks after transplantation.

In this study of 16 HIV positive participants with blood cancer, the researchers show that stem cell transplantation promotes reactivation of the virus within the patient's remaining original immune cells. This leads to some of the new immune cells becoming infected, thus 're-seeding' HIV within the host.

'Additional immunotherapy or gene therapy may be required to achieve ongoing, spontaneous control of HIV infection in people with HIV after allogeneic stem cell transplantation,' said Dr Schulze zur Wiesch. 

This research was published in Science Translational Medicine.

Critical window for re-infection with HIV after stem cell transplantation
German Centre for Infection Research |  7 May 2020
Vulnerability to reservoir reseeding due to high immune activation after allogeneic hematopoietic stem cell transplantation in individuals with HIV-1
Science Translational Medicine |  6 May 2020
23 August 2021 - by Elissar Gerges 
Moderna has started a trial for its HIV vaccine, based on mRNA technology...
16 March 2020 - by Dr Jennifer Frosch 
Three years after receiving a stem cell transplant, a man from London is the second patient in history to be cured of HIV, doctors report...
2 December 2019 - by Dr Kimberley Bryon-Dodd 
The first sperm bank in the world for HIV positive donors has been launched in New Zealand...
8 July 2019 - by Dr Melanie Krause 
For the first time, US researchers have used a combination of genome editing and antiretroviral therapy to eliminate HIV from mice...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.